Literature DB >> 25892143

EGFR inhibition for recurrent or metastatic HNSCC.

Athanassios Argiris1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25892143     DOI： 10.1016/S1470-2045(15)70178-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  9 in total

1.  Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation.

Authors:  Brian F Kiesel; Robert A Parise; Jianxia Guo; Donna M Huryn; Paul A Johnston; Raffaele Colombo; Malabika Sen; Jennifer R Grandis; Jan H Beumer; Julie L Eiseman
Journal:  Cancer Chemother Pharmacol       Date:  2016-10-24       Impact factor: 3.333

2.  EGFR and Cortactin: Markers for potential double target therapy in oral squamous cell carcinoma.

Authors:  Oliver Bissinger; Andreas Kolk; Enken Drecoll; Melanie Straub; Christina Lutz; Klaus-Dietrich Wolff; Carolin Götz
Journal:  Exp Ther Med       Date:  2017-09-18       Impact factor: 2.447

3.  Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.

Authors:  Li-Hsing Chi; Wei-Min Chang; Yu-Chan Chang; Yung-Chieh Chan; Chia-Chen Tai; Kam-Wing Leung; Chi-Long Chen; Alexander Th Wu; Tsung-Ching Lai; Yu-Chuan Jack Li; Michael Hsiao
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

Review 4.  Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck.

Authors:  Athanassios Argiris; Kevin J Harrington; Makoto Tahara; Jeltje Schulten; Pauline Chomette; Ana Ferreira Castro; Lisa Licitra
Journal:  Front Oncol       Date:  2017-05-09       Impact factor: 6.244

5.  Impact of HPV infection on oral squamous cell carcinoma.

Authors:  Carolin Götz; Enken Drecoll; Melanie Straub; Oliver Bissinger; Klaus-Dietrich Wolff; Andreas Kolk
Journal:  Oncotarget       Date:  2016-11-22

6.  MicroRNA-141 suppresses growth and metastatic potential of head and neck squamous cell carcinoma.

Authors:  Zhiguo Zhao; Dan Gao; Tie Ma; Liping Zhang
Journal:  Aging (Albany NY)       Date:  2019-02-08       Impact factor: 5.682

7.  Knockdown of LncRNA RHPN1-AS1 Inhibits Cell Migration, Invasion and Proliferation in Head and Neck Squamous Cell Carcinoma.

Authors:  Xiaowen Qiu; Zhuo Lei; Zeyou Wang; Yuming Xu; Chang Liu; Panchun Li; Hanjiang Wu; Zhaojian Gong
Journal:  J Cancer       Date:  2019-07-05       Impact factor: 4.207

8.  SFRP1 in Skin Tumor Initiation and Cancer Stem Cell Regulation with Potential Implications in Epithelial Cancers.

Authors:  Raghava R Sunkara; Rahul M Sarate; Priyanka Setia; Sanket Shah; Sanjay Gupta; Pankaj Chaturvedi; Poonam Gera; Sanjeev K Waghmare
Journal:  Stem Cell Reports       Date:  2020-01-09       Impact factor: 7.765

Review 9.  Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation.

Authors:  Robert L Ferris; Heinz-Josef Lenz; Anna Maria Trotta; Jesús García-Foncillas; Jeltje Schulten; François Audhuy; Marco Merlano; Gerard Milano
Journal:  Cancer Treat Rev       Date:  2017-12-02       Impact factor: 12.111
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.